ClinicalTrials.Veeva

Menu

Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs

Boston Children's Hospital logo

Boston Children's Hospital

Status

Completed

Conditions

Cystic Fibrosis

Study type

Observational

Funder types

Other

Identifiers

NCT00590330
X07-10-0407

Details and patient eligibility

About

The purpose of this study is to identify all the bacterial species present in the respiratory tracts of patients with Cystic Fibrosis (CF), and to connect them with clinical information. Traditional culture methods of throat swab and sputum samples can only identify the most prevalent bacteria in samples, those of which there are over about 5 million bacteria per teaspoon. A recently developed method has been found to be more sensitive and can detect up to several hundred bacterial species in throat swab or sputum sample of individual CF patients.

Full description

This study does not include testing of any investigational drugs and this is a noninvasive study requiring only a sputum/swab sample paired with information contained in the routine clinic letters and laboratory results your CF physicians obtain at your regular clinic visits.

Enrollment

55 patients

Sex

All

Ages

1 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Between the ages of 1-16 upon enrollment
  • Diagnosis of Cystic Fibrosis

Exclusion criteria

  • None

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems